|
GPAM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.54629999999623E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.039500E-03 |
| Normal-vs-Stage2 |
3.811600E-01 |
| Normal-vs-Stage3 |
1.81065000000036E-05 |
| Normal-vs-Stage4 |
1.0498000000414E-06 |
| Stage1-vs-Stage2 |
2.494600E-01 |
| Stage1-vs-Stage3 |
1.201000E-01 |
| Stage1-vs-Stage4 |
1.715770E-02 |
| Stage2-vs-Stage3 |
1.339610E-02 |
| Stage2-vs-Stage4 |
4.215700E-03 |
| Stage3-vs-Stage4 |
3.434000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48329999996688E-06 |
| Normal-vs-AfricanAmerican |
5.362400E-01 |
| Normal-vs-Asian |
1.90636999999327E-05 |
| Caucasian-vs-AfricanAmerican |
1.102430E-01 |
| Caucasian-vs-Asian |
5.721200E-01 |
| AfricanAmerican-vs-Asian |
1.262440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.041900E-02 |
| Normal-vs-Female |
3.50890000000437E-05 |
| Male-vs-Female |
2.726600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.660950E-03 |
| Normal-vs-Age(41-60Yrs) |
9.85279999999866E-05 |
| Normal-vs-Age(61-80Yrs) |
2.014300E-02 |
| Normal-vs-Age(81-100Yrs) |
9.102200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.124000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.590200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.475800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.674600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.416610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.049800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.15810028233909E-10 |
| Classical-VS-Follicular |
7.21320000396375E-08 |
| Classical-VS-Other |
4.622200E-03 |
| Classical-VS-Normal |
1.05819999995926E-06 |
| Tall-VS-Follicular |
1.6295853555448E-12 |
| Tall-VS-Other |
1.608420E-01 |
| Tall-VS-Normal |
1.62647673107585E-12 |
| Follicular-VS-Other |
2.6002000552694E-10 |
| Follicular-VS-Normal |
9.995800E-02 |
| Other-VS-Normal |
2.23430000056979E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.814200E-02 |
| Normal-vs-N1 |
1.38819955530778E-10 |
| N0-vs-N1 |
1.37709999958879E-07 |
|
|
